359 related articles for article (PubMed ID: 11581212)
1. Antiviral activity and ocular kinetics of antisense oligonucleotides designed to inhibit CMV replication.
Henry SP; Miner RC; Drew WL; Fitchett J; York-Defalco C; Rapp LM; Levin AA
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2646-51. PubMed ID: 11581212
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human cytomegalovirus replication in a human retinal epithelial cell model by antisense oligonucleotides.
Detrick B; Nagineni CN; Grillone LR; Anderson KP; Henry SP; Hooks JJ
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):163-9. PubMed ID: 11133862
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of an antisense oligonucleotide injected intravitreally in monkeys.
Leeds JM; Henry SP; Bistner S; Scherrill S; Williams K; Levin AA
Drug Metab Dispos; 1998 Jul; 26(7):670-5. PubMed ID: 9660849
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of a potential human cytomegalovirus therapeutic, a phosphorothioate oligonucleotide, after intravitreal injection in the rabbit.
Leeds JM; Henry SP; Truong L; Zutshi A; Levin AA; Kornbrust D
Drug Metab Dispos; 1997 Aug; 25(8):921-6. PubMed ID: 9280399
[TBL] [Abstract][Full Text] [Related]
5. Disposition and toxicity of a mixed backbone antisense oligonucleotide, targeted against human cytomegalovirus, after intravitreal injection of escalating single doses in the rabbit.
Dvorchik BH; Marquis JK
Drug Metab Dispos; 2000 Oct; 28(10):1255-61. PubMed ID: 10997948
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal pharmacokinetics and retinal concentrations of ganciclovir and foscarnet after intravitreal administration in rabbits.
López-Cortés LF; Pastor-Ramos MT; Ruiz-Valderas R; Cordero E; Uceda-Montañés A; Claro-Cala CM; Lucero-Muñoz MJ
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1024-8. PubMed ID: 11274081
[TBL] [Abstract][Full Text] [Related]
7. Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.
Orr RM
Curr Opin Mol Ther; 2001 Jun; 3(3):288-94. PubMed ID: 11497353
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and metabolism in mice of a phosphorothioate oligonucleotide antisense inhibitor of C-raf-1 kinase expression.
Geary RS; Leeds JM; Fitchett J; Burckin T; Truong L; Spainhour C; Creek M; Levin AA
Drug Metab Dispos; 1997 Nov; 25(11):1272-81. PubMed ID: 9351904
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
Crooke ST; Graham MJ; Zuckerman JE; Brooks D; Conklin BS; Cummins LL; Greig MJ; Guinosso CJ; Kornbrust D; Manoharan M; Sasmor HM; Schleich T; Tivel KL; Griffey RH
J Pharmacol Exp Ther; 1996 May; 277(2):923-37. PubMed ID: 8627575
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species.
Geary RS; Yu RZ; Watanabe T; Henry SP; Hardee GE; Chappell A; Matson J; Sasmor H; Cummins L; Levin AA
Drug Metab Dispos; 2003 Nov; 31(11):1419-28. PubMed ID: 14570775
[TBL] [Abstract][Full Text] [Related]
11. Preclinical pharmacokinetics of Ranibizumab (rhuFabV2) after a single intravitreal administration.
Gaudreault J; Fei D; Rusit J; Suboc P; Shiu V
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):726-33. PubMed ID: 15671306
[TBL] [Abstract][Full Text] [Related]
12. Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation.
Cheng L; Hostetler KY; Chaidhawangul S; Gardner MF; Beadle JR; Keefe KS; Bergeron-Lynn G; Severson GM; Soules KA; Mueller AJ; Freeman WR
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1523-32. PubMed ID: 10798672
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics, tissue distribution, and stability of antisense oligodeoxynucleotide phosphorothioate ISIS 3466 in mice.
Saijo Y; Perlaky L; Wang H; Busch H
Oncol Res; 1994; 6(6):243-9. PubMed ID: 7865900
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice.
Yu RZ; Zhang H; Geary RS; Graham M; Masarjian L; Lemonidis K; Crooke R; Dean NM; Levin AA
J Pharmacol Exp Ther; 2001 Feb; 296(2):388-95. PubMed ID: 11160622
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of retinal toxicity and efficacy of anti-cytomegalovirus and anti-herpes simplex virus antiviral phosphorothioate oligonucleotides ISIS 2922 and ISIS 4015.
Flores-Aguilar M; Besen G; Vuong C; Tatebayashi M; Munguia D; Gangan P; Wiley CA; Freeman WR
J Infect Dis; 1997 Jun; 175(6):1308-16. PubMed ID: 9180168
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and posterior segment biodistribution of ESBA105, an anti-TNF-alpha single-chain antibody, upon topical administration to the rabbit eye.
Furrer E; Berdugo M; Stella C; Behar-Cohen F; Gurny R; Feige U; Lichtlen P; Urech DM
Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):771-8. PubMed ID: 18757508
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats.
Cossum PA; Truong L; Owens SR; Markham PM; Shea JP; Crooke ST
J Pharmacol Exp Ther; 1994 Apr; 269(1):89-94. PubMed ID: 8169856
[TBL] [Abstract][Full Text] [Related]
18. In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides.
Crooke RM; Graham MJ; Cooke ME; Crooke ST
J Pharmacol Exp Ther; 1995 Oct; 275(1):462-73. PubMed ID: 7562586
[TBL] [Abstract][Full Text] [Related]
19. Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100.
Yu RZ; Kim TW; Hong A; Watanabe TA; Gaus HJ; Geary RS
Drug Metab Dispos; 2007 Mar; 35(3):460-8. PubMed ID: 17172312
[TBL] [Abstract][Full Text] [Related]
20. A nonradioisotope biomedical assay for intact oligonucleotide and its chain-shortened metabolites used for determination of exposure and elimination half-life of antisense drugs in tissue.
Geary RS; Matson J; Levin AA
Anal Biochem; 1999 Oct; 274(2):241-8. PubMed ID: 10527522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]